Alamandine is primarily studied for its potential therapeutic applications in cardiovascular health. It has shown promise in reducing blood pressure and improving heart function, particularly in conditions like hypertension and heart failure. Alamandine works by interacting with the Mas-related G protein-coupled receptor, which helps regulate vascular tone and fluid balance. Additionally, it may have anti-fibrotic effects, making it a candidate for treating organ fibrosis, such as in the heart, kidneys, or lungs. Research is also exploring its role in mitigating inflammation and oxidative stress, which are key factors in various chronic diseases. While still in the experimental stage, Alamandine holds significant potential for developing treatments for cardiovascular and fibrotic disorders.